Curis Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Apr 30 Calls Today's Calls

Call Details Curis Earnings Conference Call (Q1 2008) Wed, Apr 30, 2008, 9:00 am Eastern Listen to the archived event audio About Curis (NasdaqGM:CRIS) Curis, Inc., a drug discovery and development company, focuses on the development of medicines primarily in the field of cancer. The company’s product development approach involves using small molecules, proteins, or antibodies to modulate the biological signaling pathways. The biological signaling pathways are the means by which cells exchange instructional messages that regulate specific biological functions. Curis is developing various preclinical product candidates in the fields of cancer, nervous system disorders, hair growth, kidney diseases, and cardiovascular diseases. The company is developing its product candidate programs around various signaling pathways, including the Hedgehog and Bone Morphogenetic Protein pathways. It has strategic collaborations with Genentech, The Procter & Gamble Company, and Wyeth Pharmaceuticals to develop therapeutics, which modulate the signaling of the Hedgehog pathway; an additional collaboration with Genentech for discovery and development of small molecule compounds that modulate a signaling pathway that plays an important role in cell proliferation; and a collaboration agreement with Procter & Gamble Pharmaceuticals to evaluate and develop treatments for hair growth regulation and skin disorders utilizing Curis' Hedgehog agonist technology. Curis was founded in 2000 and is headquartered in Cambridge, Massachusetts. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials